Loading clinical trials...
Loading clinical trials...
The medium cut-off dialysis membrane has been developed to provide a significantly extended molecular cut-off compared to conventional high-flux membranes. The medium cut-off membrane allows for a hig...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vantive Health LLC
Collaborators
NCT06935838 · Obesity and Overweight, HIV, and more
NCT06363253 · Obesity, Sarcopenia, and more
NCT04799275 · Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma, and more
NCT05949281 · Type 1 Diabetes, Cardiovascular Diseases, and more
NCT05507541 · Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, and more
Martin-Luther-Universität Halle-Wittenberg
Halle, Saxony-Anhalt
Charité - Universitätsmedizin Berlin
Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions